Both in Medical Labs
Sera Prognostics vs Exagen
Over the past year SERA returned −34.1% and XGN returned −22.9%; their daily moves had a correlation of 0.07.
SERA −34.1% XGN −22.9%Growth of $1, one year, split-adjusted
| Metric | SERA | XGN |
|---|---|---|
| Price | $2.01 | $8.30 |
| Market cap | $79.3M | $201.1M |
| Today | −0.49% | −2.12% |
| 1 month | −2.9% | +12.3% |
| 6 months | +4.7% | +213.2% |
| Year to date | −31.9% | +36.5% |
| 1 year | −35.0% | −23.8% |
| Revenue growth (YoY) | +76.5% | +15.9% |
| Gross margin | −66.7% | 61.3% |
| Net margin | −30463.3% | −16.0% |
| P/E (TTM) | — | — |
| Price / sales | 1,132.8× | 2.8× |
| Net cash | $46.4M | -$959.0K |
| Dividend yield | — | — |
| Volatility (60d) | 53.1% | 89.4% |
| Short % of float | 0.7% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).